Humana Inc. $HUM Holdings Reduced by South Dakota Investment Council

South Dakota Investment Council lowered its position in Humana Inc. (NYSE:HUM – Free Report) by 48.1% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 40,975 shares of the insurance provider’s stock after selling 37,921 shares during the quarter. South Dakota Investment Council’s holdings in Humana were worth $15,635,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently made changes to their positions in the business. Rothschild Investment LLC grew its holdings in Humana by 9.4% in the 3rd quarter. Rothschild Investment LLC now owns 279 shares of the insurance provider’s stock worth $106,000 after buying an additional 24 shares in the last quarter. Pinnacle Wealth Planning Services Inc. increased its position in Humana by 21.8% in the 3rd quarter. Pinnacle Wealth Planning Services Inc. now owns 151 shares of the insurance provider’s stock valued at $58,000 after acquiring an additional 27 shares during the period. Wilkerson Advisory Group LLC raised its stake in Humana by 24.6% during the 2nd quarter. Wilkerson Advisory Group LLC now owns 167 shares of the insurance provider’s stock valued at $66,000 after acquiring an additional 33 shares in the last quarter. Moors & Cabot Inc. raised its stake in Humana by 4.3% during the 3rd quarter. Moors & Cabot Inc. now owns 804 shares of the insurance provider’s stock valued at $307,000 after acquiring an additional 33 shares in the last quarter. Finally, Cidel Asset Management Inc. boosted its position in Humana by 1.1% during the 2nd quarter. Cidel Asset Management Inc. now owns 3,883 shares of the insurance provider’s stock worth $1,542,000 after acquiring an additional 41 shares during the period. Institutional investors own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

HUM has been the subject of several recent analyst reports. Lake Street Capital initiated coverage on Humana in a research note on Thursday, July 30th. They issued a “buy” rating for the company. Piper Sandler lifted their price objective on shares of Humana from $463.00 to $526.00 and gave the company an “overweight” rating in a research note on Monday, November 9th. Truist Financial upped their price objective on shares of Humana from $415.00 to $475.00 and gave the stock a “hold” rating in a report on Monday, October 12th. Evercore raised shares of Humana from an “in-line” rating to an “outperform” rating and set a $480.00 price objective for the company in a report on Wednesday, July 29th. Finally, Leerink Partners upgraded shares of Humana from a “market perform” rating to an “outperform” rating and set a $513.00 target price for the company in a research report on Thursday, July 30th. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $484.78.

View Our Latest Stock Report on Humana

Insiders Place Their Bets

In other news, insider Joseph Ventura sold 5,495 shares of the firm’s stock in a transaction dated Monday, November 9th. The shares were sold at an average price of $433.85, for a total transaction of $2,384,005.75. Following the completion of the transaction, the insider owned 21,910 shares in the company, valued at approximately $9,505,653.50. This trade represents a 20.05% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 0.20% of the company’s stock.

Humana Stock Performance

HUM opened at $442.84 on Wednesday. The company has a market capitalization of $53.19 billion, a price-to-earnings ratio of 43.08, a price-to-earnings-growth ratio of 2.20 and a beta of 0.65. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.65 and a quick ratio of 1.65. Humana Inc. has a 1-year low of $163.11 and a 1-year high of $462.87. The business has a 50 day moving average price of $410.55 and a two-hundred day moving average price of $319.48.

Humana (NYSE:HUM – Get Free Report) last issued its quarterly earnings results on Friday, November 6th. The insurance provider reported ($0.70) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.00) by $0.30. The company had revenue of $41.16 billion for the quarter, compared to analysts’ expectations of $40.87 billion. Humana had a return on equity of 8.50% and a net margin of 0.81%. The firm’s revenue for the quarter was up 26.1% on a year-over-year basis. During the same period last year, the firm earned $3.24 EPS. Humana has set its FY 2026 guidance at 9.500- EPS. Research analysts predict that Humana Inc. will post 9.66 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 29th. Shareholders of record on Thursday, December 24th will be issued a $0.8850 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Thursday, December 24th. Humana’s dividend payout ratio is presently 34.44%.

Recent Humana Headlines

These are some of the HUM headlines that stood out recently:

Humana Profile

(Free Report)

Humana Inc. is a U.S. health and wellness company that provides health insurance and healthcare services. Its insurance offerings include Medicare Advantage, Medicare Supplement and prescription drug plans, as well as Medicaid and employer-sponsored plans. The company also provides care through CenterWell, its healthcare services brand, which includes primary care, home health and pharmacy services. Its insurance and care offerings are available in markets across the United States, with availability varying by product and location.

Recommended Stories

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.